EXO Biologics
Develops biopharmaceuticals using extracellular vesicles for therapeutic purposes.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—54m (Dealroom.co estimates Apr 2024.)
Liège Liège (HQ)
Authorizing premium user...